REDUCED BETA-AMYLOID RESPONSE IN LYMPHOCYTES OF PATIENTS WITH ALZHEIMERS-DISEASE

被引:12
|
作者
BONDY, B
HOFMANN, M
NULLERSPAHN, F
WITZKO, M
HOCK, C
机构
[1] Psychiatrische Klinik, Universitat Munchen, D-80336 Munchen
关键词
D O I
10.1055/s-2007-979606
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta-amyloid peptide (beta A4) is a principal constituent of senile plagues and is thought to play a major role in the pathophysiology of Alzheimer's disease (AD). Although the mechanism of beta-A4 neurotoxicity is still a matter of debate, one of its effects might be a destabilization of cellular calcium homeostasis, thus promoting neuronal damage. The influence of the toxic fragment beta A25-35 on the mitogen-induced rise in the intracellular calcium concentration ([Ca2+](i)) in lymphocytes of AD (n=13) and depressive patients (n=14) as well as in healthy controls was therefore investigated (n=16), The results showed a significant increase in the mitogen-induced calcium signal with lymphocytes of healthy controls and depressive patients. This beta A25-35-induced amplification was significantly lower in AD patients as compared to healthy controls but not as compared to depressive patients. The results thus confirm a postulated decreased beta-amyloid sensitivity in AD lymphocytes. However, this effect might not be as pronounced or as specific as recently decribed by Eckert et al., (1993b).
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [1] ALZHEIMERS-DISEASE AND BETA-AMYLOID - PREFACE
    TABIRA, T
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 174 (03): : U5 - U6
  • [2] ALZHEIMERS-DISEASE AND BETA-AMYLOID - ABSTRACTS
    不详
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 174 (03): : A1 - A3
  • [3] BETA-AMYLOID PROTEIN IN ALZHEIMERS-DISEASE
    NALBANTOGLU, J
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 18 (03) : 424 - 427
  • [4] ALZHEIMERS-DISEASE AND BETA-AMYLOID - REPLY
    YANKNER, BA
    MESULAM, MM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19): : 1292 - 1293
  • [5] ALZHEIMERS-DISEASE AND THE BETA-AMYLOID GENE
    HARRISON, PJ
    [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6791): : 1478 - 1479
  • [6] THE RELEASE OF ALZHEIMERS-DISEASE BETA-AMYLOID PEPTIDE IS REDUCED BY PHORBOL TREATMENT
    JACOBSEN, JS
    SPRUYT, MA
    BROWN, AM
    SAHASRABUDHE, SR
    BLUME, AJ
    VITEK, MP
    MUENKEL, HA
    SONNENBERGREINES, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (11) : 8376 - 8382
  • [7] BETA-AMYLOID GENE DOSAGE IN ALZHEIMERS-DISEASE
    MURDOCH, GH
    MANUELIDIS, L
    KIM, JH
    MANUELIDIS, EE
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (01) : 357 - 357
  • [8] DECREASED BETA-AMYLOID SENSITIVITY IN ALZHEIMERS-DISEASE
    ECKERT, A
    FORSTL, H
    HARTMANN, H
    MULLER, WE
    [J]. LANCET, 1993, 342 (8874): : 805 - 806
  • [9] ROLE OF THE BETA-AMYLOID PROTEIN IN ALZHEIMERS-DISEASE
    SISODIA, SS
    PRICE, DL
    [J]. FASEB JOURNAL, 1995, 9 (05): : 366 - 370
  • [10] NEURODEGENERATION, ALZHEIMERS-DISEASE, AND BETA-AMYLOID TOXICITY
    HOYER, S
    [J]. LIFE SCIENCES, 1994, 55 (25-26) : 1977 - 1983